- Report of Foreign Issuer (6-K)
22 Octubre 2012 - 9:04AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
October 22, 2012
Commission File Number: 000-50867
Syneron Medical Ltd.
(Translation of registrant’s name
into English)
Industrial Zone, Yokneam Illit 20692,
P.O.B. 550, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F
S
Form
40-F
£
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether by furnishing
the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to
Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
£
No
S
If “Yes” is marked, indicate
below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________
Attached hereto and incorporated herein
by reference is a press release of the Company, dated October 22, 2012, entitled “Syneron Announces Availability of elōs
Plus™ in Canada
Following Health Canada Clearance.”
This Form 6-K is incorporated by reference
into the Company’s Registration Statements on Form S-8 filed with the Securities and Exchange Commission on November 16,
2004 (Registration No. 333-120559), on January 8, 2010 (Registration No. 333-164250) and on January 15, 2010 (Registration No.
333-164351).
Signatures
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
SYNERON MEDICAL LTD.
|
|
|
|
|
|
By:
|
/s/ David Schlachet
|
|
|
Name: David Schlachet
Title: Chief Financial Officer
|
Date: October 22, 2012
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Syneron Medical Ltd. - Ordinary Shares (NASDAQ:ELOS)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024